Clinical profile of various sub-types of writer's cramp

Parkinsonism and Related Disorders

Volumn 13, Issue 7, 2007, Pages 421-424

  Das, Chandi Prasad ^a   Prabhakar, Sudesh ^a   Truong, Daniel ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Parkinson's and Movement Disorder Institute   (United States)

Author keywords

Presentation; Sub types; Treatment; Writer's cramp

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; CENTRAL MUSCLE RELAXANT; CLONAZEPAM; TETRABENAZINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DYSTONIA; FEMALE; FOCAL WRITER CRAMP; GENERALIZED WRITER CRAMP; HANDWRITING; HUMAN; MALE; MEIGE DISEASE; MUSCLE CRAMP; OCCUPATIONAL DISEASE; PRIORITY JOURNAL; RATING SCALE; SEDATION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WORK DISABILITY; XEROSTOMIA;

ADULT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DISABILITY EVALUATION; DRUG ADMINISTRATION ROUTES; DYSTONIC DISORDERS; FEMALE; HUMANS; MALE; MEIGE SYNDROME; MIDDLE AGED; POSTURE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 34548844187     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.01.009     Document Type: Article

References (17)

1. Sheehy M.P., and Marsden C.D. Writers' cramp-a focal dystonia. Brain 105 (1982) 461-480
2. Gower W. A manual of diseases of the nervous system (1888), Churchill, London p. 656-74
3. Ramazzini B. Diseases of workers translated from De Morbis artificum diatriba of 1713 (1964), Haffner, New York
4. Altschuler E.L. Ramazzini and writer's cramp (2005), Lancet 365: 938
5. Jedynak P.C., Tranchant C., and de Beyl D.Z. Prospective clinical study of writer's cramp. Mov Disord 16 (2001) 494-499
6. Deuschl G., Heinen F., Guschlbauer B., Schneider S., Glocker F.X., and Lucking C.H. Hand tremor in patients with spasmodic torticollis. Mov Disord 12 (1997) 547-552
7. Burke R.E., Fahn S., Marsden C.D., Bressman S.B., Moskowitz C., and Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35 (1985) 73-77
8. Duffey P.O., Butler A.G., Hawthorne M.R., and Barnes M.P. The epidemiology of the primary dystonias in the north of England. Adv Neurol 78 (1998) 121-125
9. A prevalence study of primary dystonia in eight European countries. J Neurol 2000; 247: 787-92.
10. Sex-related influences on the frequency and age of onset of primary dystonia. Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group. Neurology 1999; 53: 1871-3.
11. Soland V.L., Bhatia K.P., and Marsden C.D. Sex prevalence of focal dystonias. J Neurol Neurosurg Psychiatry 60 (1996) 204-205
12. Karp B.I., Cole R.A., Cohen L.G., Grill S., Lou J.S., and Hallett M. Long-term botulinum toxin treatment of focal hand dystonia. Neurology 44 (1994) 70-76
13. Djebbari R., du Montcel S.T., Sangla S., Vidal J.S., Gallouedec G., and Vidailhet M. Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin. J Neurol Neurosurg Psychiatry 75 (2004) 1688-1691
14. Waddy H.M., Fletcher N.A., Harding A.E., and Marsden C.D. A genetic study of idiopathic focal dystonias. Ann Neurol 29 (1991) 320-324
15. Rivest J., Lees A.J., and Marsden C.D. Writer's cramp: treatment with botulinum toxin injections. Mov Disord 6 (1991) 55-59
16. Turjanski N., Pirtosek Z., Quirk J., Anderson T.J., Rivest J., Marsden C.D., et al. Botulinum toxin in the treatment of writer's cramp. Clin Neuropharmacol 19 (1996) 314-320
17. Tsui J.K., Bhatt M., Calne S., and Calne D.B. Botulinum toxin in the treatment of writer's cramp: a double-blind study. Neurology 43 (1993) 183-185